Posted by Chiara |
Posted in Events |
Comments Off
April 30, 2012 | 8:56 am
The pharmaceutical industry unfortunately is viewed negatively by the public, who believes that companies do little to ensure the safety of its medicines and that the main goal is to make profits at the expense of an unsuspecting public. Furthermore, people believe that drugs are really discovered in universities, research institutes or the NIH and that pharmaceutical companies simply license and manufacture new medicines. This is simply untrue. This talk will give concrete examples of the value that the pharmaceutical industry adds to the overall healthcare system.
John LaMattina was the Senior Vice President, Pfizer Inc. and President, Pfizer Global Research and Development. In this role, he oversaw the drug discovery and development efforts of more than 12,000 colleagues in the United States, Europe and Asia. LaMattina joined Pfizer as a medicinal chemist in 1997 and over the years, he held positions of increasing responsibility for Pfizer Central Research, including Vice President of U.S. Discovery Operations in 1993, Senior Vice President of Worldwide Discovery Operations in 1998 and Senior Vice President of Worldwide Development in 1999.
During his tenure as Head of Global R&D, Pfizer produced new treatments for cancer, smoking cessation rheumatoid arthritis and AIDS. Dr. LaMattina is the author of numerous scientific publications, holds a number of U.S. patents and he is the author of “Drug Truths: Dispelling the Myths About Pharma R&D.” Dr. LaMattina has received a number of awards including the 1998 Boston College Alumni Award of Excellence in Science, an Honorary Doctor of Science degree from the University of New Hampshire in 2007, and the 2010 American Chemical Society Earle Barnes Award for Leadership in Chemical Research Management.
Dr. LaMattina is a Senior Partner at PureTech Ventures, he serves on the Board of Directors of Human Genome Sciences, the Board of Directors of Ligand Pharmaceuticals, and the Scientific Advisory Board of Trevena.
Posted by Julie |
Posted in Events |
Comments Off
| 8:45 am
The 2012 SEBIO Investor Forum connects investors and emerging companies. There will be more than 30 emerging life sciences and medical technologies companies presenting to an audience of over 350 attendees. The forum provides an opportunity for presenting companies to increase visibility to investors, industry partners, and media exposure. Early stage companies also benefit from a private advisory session with experienced business professionals. Companies also have increased access to SEBIO and the opportunity to arrange one-on-one meetings. Representatives from presenting companies will receive complimentary registration.
Date October 31 – November 1, 2012 Location The Breakers Palm Beach, Florida Apply SEBIO 2012 Investor Forum Applications due Friday, June 29, 2012.
Posted by Julie |
Posted in Events |
Comments Off
April 19, 2012 | 1:38 pm
Oliver Platt Mills
Adam Kerpelman
U.Va. Innovation invites you to attend the April installment of our Innovation Roundtable series with Adam Kerpelman and Oliver Platt-Mills. Please join us for networking with University and community innovators, with food and refreshments provided. Kerpelman will disuss his recent involvement with the Startup Bus-Washington and Oliver Platt-Mills will speak about his vision behind the Tom-Tom Festival. The Innovation Roundtable will be held at CitySpace (100 5th St. NE) on the Downtown Mall, above the Market St. Garage.
Posted by Chiara |
Posted in Events |
Comments Off
April 16, 2012 | 8:40 am
By Brevy Cannon U.Va. Today News Release
2011 Venture Summit
Technology and business ventures with ties to the University of Virginia will be pitched to an audience of investors from across the country, representing roughly $20 billion in active capital funds, at U.Va.’s fourth annual Venture Summit, being held April 19 in the Old Cabell Hall auditorium and April 20 in room 50 at the Darden School of Business.
At the past three summits, “between two-thirds and three-quarters” of the presenting start-ups found funding from investors attending the summit, said W. Mark Crowell, executive director of U.Va. Innovation and associate vice president for research. The annual event is perhaps the best example of U.Va.’s efforts to become an ever-stronger engine of innovation and job creation powered by fundamental research, Crowell said. And the success of those efforts is starting to get noticed in Congress. On Thursday morning at 10, U.S. Sen. Mark Warner (D-Va.) will discuss (via video link if the Senate is in session) the Start Up Act (S.1965), legislation he introduced in December that would promote innovation and start up businesses by relaxing several tax and regulatory hurdles.
One of the bill’s most significant provisions, dealing with ways to speed up the transfer of research and technology from university laboratories to the marketplace, was written with major input from U.Va., Crowell said.
In the six years from 2006 through 2011, U.Va. researchers reported the invention of 981 technologies, 341 of which have been licensed to companies and institutions for further development. U.Va. researchers were awarded 37 patents in 2011, 32 in 2010, and 128 total from 2006 through 2011. More than 600 of the University’s early-stage research discoveries have been put on the path to commercialization, many through strategic research partnerships with major corporations and industry leaders such as AstraZeneca, Johnson & Johnson and Rolls-Royce.
“The University of Virginia has rapidly become a global destination for technology-based venture creation,” Thomas C. Skalak, vice president for research, said.
As part of the Venture Summit’s focus on big-picture innovation and technology transfer issues, Aneesh Chopra, who stepped down in January as the nation’s first U.S. chief technology officer, will be part of a panel discussion on Thursday, “Innovation: A New Day in the U.S.” Vonage CEO Marc Lefar and Weather Channel CEO David Kenny will discuss “Opportunities and Challenges for Traditional Businesses in a Digital World.”
Thursday’s public events will conclude with a panel of veteran venture capitalists who will discuss the state of the venture capital industry. Five Charlottesville-based companies – Cardagin, Diffusion Pharmaceuticals, iTi Health, Lend Street and ProteiosBio, all founded or led by a U.Va. alumnus, faculty or staff member or student, or based on a technology developed at the University – will participate in the summit’s interactive showcase, on Friday from 9 to 11:30 a.m. in room 50 at the Darden School of Business. Each company will pitch to an audience of investors, followed by a question-and-answer period. Presenters will then receive feedback from a panel of experienced investors including Jonathan Aberman, founder managing director of Amplifier Ventures; Doug Garland, chief revenue officer of Shazam; Cody Nystrom, a senior associate at SJF Ventures; and Rob Patzig, senior managing director and chief investment officer at Third Security.
After that, the investor panel will also hear pitches from and give feedback to four student-led startup business plans: the two top finishers from this year’s Darden Business Plan Competition, held Thursday – WalkBack and RadioFetch – and the two top finishers in the last U.Va. Entrepreneurship Cup, held in November: Memoria and Powersole.
“To be able to pitch and receive invaluable feedback from this elite group is really a tremendous opportunity for our innovative U.Va. and community entrepreneurs,” Crowell said.
Meet other life science professionals, students and university researchers from the area in a casual social environment. Come meet and listen to remarks from Aneesh Chopra, the first and former U.S. Chief Technology Officer.
Posted by Chiara |
Posted in Events |
Comments Off
April 3, 2012 | 11:30 am
The Women in Math and Science (WIMS) organization at the University of Virginia will be hosting an event entitled “After the Ph.D.: Non-Academic Careers in Science and Math.” The event will feature speakers in various non-academic careers including government agencies, industry, science writing and publishing. The keynote speaker is Jane Chin, who received her Ph.D. in biochemistry from University of Buffalo at Roswell Park Cancer Institute, and later became a medical science liaison and is a well-known writer and public speaker. She is the author of PhD [alternative] Career Clinic, a guide to successfully make it in a non-academic world. The first panel, which will focus on life with a Ph.D. in governmental agencies, will feature U.Va. Licensing and Ventures Group‘s very own Stephanie Miller, licensing associate who received her doctoral degree in Biochemistry and Molecular Genetics from the University.
Finalists for the Charlottesville Business Innovation Council (CBIC) Awards Gala have been selected in six categories that reflect the gala’s theme: Go for the Gold! The finalists were chosen from a large group of nominees. You can choose the People’s Choice Navigator Award winner by voting online through May 1. Don’t miss the awards ceremony on May 24 5pm-10pm.
Rocket Award for rapid commercialization of a technology or product.
Posted by Chiara |
Posted in Events |
Comments Off
March 28, 2012 | 8:11 am
Hosted by Venture Forward, U.Va.’s start-up mentoring network, First Tuesdays provides new and experienced entrepreneurs with the opportunity to connect, bounce ideas off one another and get their burning questions answered. Venture Forward is a U.Va. Innovation initiative.
Aspiring and seasoned entrepreneurs from the University and the community are invited to attend this monthly gathering, held on the first Tuesday of each month. All events will be held at the OpenGrounds Corner Studio (1400 W. Main St., Charlottesville, VA 22903), with light refreshments provided. Parking is available in the 11th Street Parking Garage.
Posted by Chiara |
Posted in Events |
Comments Off
March 26, 2012 | 9:27 am
The next installment of U.Va. Innovation’s popular Innovation Roundtable seminar and networking series focuses on how MeadWestvaco, a global leader in packaging and packaging solutions, uses the principles of open innovation to tap into the expertise of employees, suppliers, customers, inventors, competitors and academics and solve its toughest challenges. Wednesday, March 28 from 5-7 p.m. at CitySpace. Register online by today, here.
Paul France is the vice president of Open Innovation at MeadWestvaco, where he leads efforts to identify, evaluate and secure breakthrough technologies. He is also responsible for knowledge management and technology partnering to accelerate growth through innovation.
Founders of life sciences startups have an opportunity to network and find answers to critical questions about how to grow viable life sciences companies at the inaugural Kauffman Life Science Ventures Summit in June, sponsored by the Ewing Marion Kauffman Foundation.
The two-day summit will feature industry experts ans successful entrepreneurs who will offer guidance on how to commercialize innovations for medical devices, therapeutics, diagnostics and digital health. The Summit’s speakers include Kim Popovits, CEO, Genomic Health (keynote); Steve Blank, serial entrepreneur and author; Stephen Spielberg, deputy commissioner for medical products and tobacco at the Food & Drug Administration; Paul Yock, founder, Stanford Biodesign; Karl Handelsman, managing director, CMEA Capital and more.
When: June 22-23, 2012
Where: Mission Bay Conference Center at the University of California-San Francisco
How to Apply: 200 life science entrepreneurs will be selected under four sectors: therapeutics, medical devices, diagnostics, and digital health, and will be accepted on how much they will benefit from the experience and the commercial viability of their plan.
Date
